Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
- Atopic Eczema
- Dermatology Life Quality Index
- Severe Atopic Eczema
- Cyclosporine Microemulsion
- Pediatric Symptom Checklist
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
All Party Parliamentary Group on Skin (2003) Report on the enquiry into the impact of skin disease on people’s lives. All Party Parliamentary Group on Skin, London
Aziah MS, Rosnah T, Mardziah A, Norzila MZ (2002) Childhood atopic dermatitis: a measurement of quality of life and family impact. Med J Malaysia 57:329–339
Balkrishnan R, Housman TS, Grummer S, Rapp SR, Clarke J, Feldman SR, Fleischer AB (2003) The family impact of atopic dermatitis in children: the role of the parent caregiver. Ped Dermatol 20:5–10
Ben-Gashir MA, Seed PT, Hay RJ (2002) Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 16:455–462
Charman C, Chambers C, Williams H (2003) Measuring atopic dermatitis severity in randomised controlled clinical trials: what exactly are we measuring? J Invest Dermatol 120:932–941
Chaudhry S Moss C Gilmour E 2001 Quality of life measurements in children with atopic eczema from different ethnic groups in Birmingham. Br J Dermatol 145[Supp
Chinn DJ, Poyner T, Sibley G (2002) Randomised controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol 146:432–439
Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ (1996) Skindex, a quality of life measure for patients with skin disease: reliability, validity and responsiveness. J Invest Dermatol 107:707–713
Czech W, Brautigam M, Weidinger G, Schopf E (2000) A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol 42:653–659
Daud L, Garrada M, David TJ (1993) Psychosocial adjustment in pre-school children with atopic eczema. Arch Dis Child 69:670–676
Drake L, Prendergast M, Maher R, Breneman D, Korman N, Satoi Y, Beusterien, Lawrence I (2001) The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 44: S65–S72
Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz, Daniel R, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW (2002) Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 46: 361–370
Emerson RM, Williams HC, Allen BR, Mehta R et al (1997) How much disability does atopic eczema cause compared to other common childhood skin problems? Br J Dermatol 137[Suppl 50]:19
Emerson RM, Williams, Allen BR (2001) What is the cost of atopic dermatitis in preschool children? Br J Dermatol 144:514–522
Finlay AY (1996) Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 135:509–515
Finlay AY (1996) Measures of the effect of severe atopic dermatitis on quality of life. J Eur Acad Dermatol Venereol 7:149–159
Finlay AY (1997) Quality of life measurement in dermatology: a practical guide. Br J Dermatol 136:305–314
Finlay AY (2001) Quality of life in atopic dermatitis. J Am Acad Dermatol 45: S64–S66
Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exper Dermatol 19:210–216
Fiveson D, Arnold RJG, Kaniecki DJ, Cohen JL, Frech F, Finlay AY (2002) The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organisation. J Managed Care Pharmacy 8:333–342
Fukuroku K, Nagano T, Ogino S (2002) Quality of life in patients with atopic dermatitis: using the Japanese version of the SF-36 health status questionnaire. Arerugi 51:1159–1169
Harper JI, Ahmed I, Barclay G et al (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142:52–58
Hermansen SE, Helland CA, Finlay AY (2002) Patients’ and doctors’ assessment of skin disease handicap. Clin Exper Dermatol 27:249–250
Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY (2003) The Children’s Dermatology Life Quality Index; validation of the cartoon version. Br J Dermatol 148:285–290
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY (2004) Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? Br J Dermatol 151(Suppl 68): 45–46
Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB, Balkrishnan R (2002) Br J Dermatol 147:1192–1198
Kemp AS (1999) Atopic eczema: its social and financial costs. J Paediatr Child Health 35:229–231
Kernick D, Cox A, Powell R, Reinhold D, Sawkins J, Warin A (2000) A cost consequence study of the impact of a dermatology-trained practice nurse on quality of life of primary care patients with eczema and psoriasis. Br J Gen Pract 50:555–558
Kiebert G, Sorenson SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, Fiveson D (2002) Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 41:151–158
Lapidus CS, Kerr PE (2001) Social impact of atopic dermatitis. Social impact of atopic dermatitis. Med Health R I 84:294–295
Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG (1998) The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 138:107–113
Lewis V, Finlay AY (2004) 10 years experience of the Dermatology Life Quality Index (DLQI). J Invest Dermatol Symp Proc 9:169–180
Lewis-Jones MS, Finlay AY (1995) The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 132:942–949
Lewis-Jones MS, Finlay AY, Dykes PJ (2001) The Infants’ Dermatitis Quality of Life Index. Br J Dermatol 144:104–110
Linnet J, Jemec GBE (1999) An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 140:268–272
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M (2000) Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 80 430–43
Morgan M, McCreedy R, Simpson J et al (1997) Dermatology Life Quality Scales — a measure of the impact of skin diseases. Br J Dermatol 136:202–206
Poyner TF, Sibley G, Chinn DJ (2001) The effects of a nurse-run clinic in primary care on the quality of life of children with atopic eczema. Br J Dermatol 145:[Suppl 59]:22–23
Rauch PK, Jellinek MS, Murphy JM, Schachner L, Hansen R, Esterly NB, Prendiville J, Bishop SJ, Goshko M (1991) Screening for psychosocial dysfunction in pediatric dermatology practice. Clin Ped 30:493–497
Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RDR et al (1993) Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomised, double-blind, placebo-controlled trial. Br J Dermatol 129:422–430
Schiffner R, Schiffner-Rohe J, Landthaler M, Stolz W (2003) Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids. Pharmacoeconomics 21:159–179
Schmid-Ott G, Kuensebeck HW, Jaeger B, Werfel T, Frahm K, Ruitman J, Kapp A, Lamprecht F (1999) Validity study for the stigmatisation experience in atopic dermatitis and psoriasis patients. Acta Derm Venereol 79:443–447
Schmid-Ott G, Burchard R, Neiderauer HH, Lambrecht F, Kunsebeck HW (2003) Stigmatisation and quality of life of patients with psoriasis and atopic dermatitis. Hautarzt 54:852–857
Shum KW, Lawton S, Williams HC, Docherty G, Jones J (2000) The British Association of Dermatologists audit of atopic eczema management in secondary care. Phase 3: audit of service outcome. Br J Dermatol 142:721–727
Smith JA (2001) The impact of skin disease on the quality of life of adolescents. Adolesc Med 12:343–353
Staab D, von Rueden U, Kehrt R, Erhart M, Wenninge K, Kamtsiuris P, Wahn U (2002) Evaluation of a parental training program for themanagement of childhood atopic dermatitis. Pediatr Allergy Immunol 13:84–90
Sugerman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams MJ (2003) The objective severity assessment of atopic dermatitis score. Arch Dermatol 139:1417–1422
European Task Force on Atopic Dermatitis (1993) Task Force severity scoring of atopic dermatitis: the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 186:23–31
Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F (2002) The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 147:716–24
Wenninger K, Kehrt R, von Ruden U, Lehmann C, Binder C, Wahn U, Staab D (2000) Structured parent education in the management of childhood atopic dermatitis: the Berlin model. Patient Educ Couns 40:253–261
Whalley D, Huels J, McKenna SP, Van Assche D (2002) The benefit of pimecrolimus (Eledil, SDZ ASM 981) on parents’ quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 110:1133–1136
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Finlay, A. (2006). The Burden of Atopic Eczema. In: Ring, J., Przybilla, B., Ruzicka, T. (eds) Handbook of Atopic Eczema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29856-8_4
Download citation
DOI: https://doi.org/10.1007/3-540-29856-8_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23133-2
Online ISBN: 978-3-540-29856-4
eBook Packages: MedicineMedicine (R0)